Status not kept up to date
Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.
NCT01448798 · Johann Wolfgang Goethe University Hospital · Updated 7 Oct 2011
- What is being tested
- Application of a hemostatic gelatin-thrombin matrix; Use of mono- and bipolar electrocautery and surgical clips
- For
- Prostate Cancer; Erectile Dysfunction
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 50 people. The full rules are on the registry page.
- Where
- Germany
- When
- Starts or started Oct 2011, ends Jan 2014. Registered 7 Oct 2011.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to evaluate the use of a hemostatic gelatine-thrombin matrix during athermal nerve-sparing prostate resection compared to conventional hemostasis using electrocautery in patients with localized prostate cancer and to investigate effects on postoperative erectile function and continence.
Sites
- Johann Wolfgang Goethe University HospitalFrankfurt/M., Germany